New Inhibitors for O-GlcNAcase
Author Information
Author(s): Helge C. Dorfmueller, Vladimir S. Borodkin, Marianne Schimpl, Xiaowei Zheng, Robert Kime, Kevin D. Read, Daan M.F. van Aalten
Primary Institution: University of Dundee
Hypothesis
Can we develop selective inhibitors for O-GlcNAcase that do not affect lysosomal hexosaminidases?
Conclusion
The new GlcNAcstatin inhibitors are highly selective for O-GlcNAcase and can penetrate live cells to induce hyper-O-GlcNAcylation.
Supporting Evidence
- The new GlcNAcstatins show up to 900,000-fold selectivity over lysosomal hexosaminidases.
- These inhibitors can penetrate live cells and induce hyper-O-GlcNAcylation.
- The EC50 values for the inhibitors are in the low nanomolar range.
Takeaway
Scientists created new drugs that can help study how a sugar modification affects cell behavior without messing with similar enzymes.
Methodology
The study involved designing and testing new inhibitors in cell-based assays and using X-ray crystallography to analyze their selectivity.
Limitations
The study does not address long-term effects of these inhibitors on cellular processes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website